lunes, 10 de marzo de 2025

Mineralys Therapeutics stock soars on blood pressure drug data The company’s drug, Lorundrostat, represents a new spin on an old approach

https://www.statnews.com/2025/03/10/mineralys-therapeutics-blood-pressure-lorundrostat/

No hay comentarios: